Manulife (Manufacturers Life Insurance)’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,350
| Closed | -$370K | – | 3079 |
|
|
2020
Q3 | $370K | Buy |
+4,350
| New | +$220K | ﹤0.01% | 2151 |
|
|
2020
Q2 | – | Sell |
-118,728
| Closed | -$1.6M | – | 2994 |
|
|
2020
Q1 | $1.6M | Buy |
118,728
+13,619
| +13% | +$229K | ﹤0.01% | 1370 |
|
|
2019
Q4 | $2.22M | Sell |
105,109
-3,490
| -3% | -$61.6K | ﹤0.01% | 1365 |
|
|
2019
Q3 | $1.55M | Buy |
108,599
+52
| +0% | +$764 | ﹤0.01% | 1454 |
|
|
2019
Q2 | $1.51M | Buy |
108,547
+10,272
| +10% | +$155K | ﹤0.01% | 1470 |
|
|
2019
Q1 | $1.89M | Buy |
98,275
+24
| +0% | +$387 | ﹤0.01% | 1436 |
|
|
2018
Q4 | $1.4M | Buy |
98,251
+6,221
| +7% | +$123K | ﹤0.01% | 1457 |
|
|
2018
Q3 | $1.92M | Sell |
92,030
-5,333
| -5% | -$126K | ﹤0.01% | 1475 |
|
|
2018
Q2 | $2.31M | Buy |
97,363
+20,732
| +27% | +$417K | ﹤0.01% | 1455 |
|
|
2018
Q1 | $1.12M | Sell |
76,631
-2,611
| -3% | -$42.7K | ﹤0.01% | 1769 |
|
|
2017
Q4 | $1.28M | Buy |
79,242
+1,538
| +2% | +$18.2K | ﹤0.01% | 1707 |
|
|
2017
Q3 | $1.09M | Sell |
77,704
-1,816
| -2% | -$18.1K | ﹤0.01% | 1737 |
|
|
2017
Q2 | $702K | Buy |
79,520
+1,763
| +2% | +$12.4K | ﹤0.01% | 2040 |
|
|
2017
Q1 | $503K | Buy |
77,757
+8,480
| +12% | +$43K | ﹤0.01% | 2184 |
|
|
2016
Q4 | $254K | Buy |
69,277
+6,543
| +10% | +$19.4K | ﹤0.01% | 2601 |
|
|
2016
Q3 | $203K | Buy |
62,734
+244
| +0.4% | +$682 | ﹤0.01% | 2766 |
|
|
2016
Q2 | $145K | Sell |
62,490
-6,050
| -9% | -$20.2K | ﹤0.01% | 2977 |
|
|
2016
Q1 | $172K | Buy |
68,540
+381
| +0.6% | +$857 | ﹤0.01% | 2706 |
|
|
2015
Q4 | $209 | Buy |
68,159
+2,213
| +3% | +$6.18K | ﹤0.01% | 2632 |
|
|
2015
Q3 | $113 | Buy |
65,946
+1,889
| +3% | +$4.82K | ﹤0.01% | 3066 |
|
|
2015
Q2 | $260 | Buy |
64,057
+6,254
| +11% | +$25.6K | ﹤0.01% | 2640 |
|
|
2015
Q1 | $222 | Buy |
57,803
+1,675
| +3% | +$7.29K | ﹤0.01% | 2659 |
|
|
2014
Q4 | $269 | Sell |
56,128
-1,144
| -2% | -$4.52K | ﹤0.01% | 2437 |
|
|
2014
Q3 | $213 | Buy |
57,272
+573
| +1% | +$1.94K | ﹤0.01% | 2600 |
|
|
2014
Q2 | $207K | Sell |
56,699
-1,072
| -2% | -$3.94K | ﹤0.01% | 2689 |
|
|
2014
Q1 | $243 | Sell |
57,771
-215
| -0.4% | -$1.07K | ﹤0.01% | 2582 |
|
|
2013
Q4 | $267 | Sell |
57,986
-782
| -1% | -$3.48K | ﹤0.01% | 2507 |
|
|
2013
Q3 | $363 | Sell |
58,768
-1,787
| -3% | -$10.3K | ﹤0.01% | 2201 |
|
|
2013
Q2 | $329K | Buy |
+60,555
| New | +$199K | ﹤0.01% | 2177 |
|
Manulife (Manufacturers Life Insurance)'s IMMU Position: Q4 2020 in Review
Manulife (Manufacturers Life Insurance) sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,350 shares — an estimated $370K sold.
Manulife (Manufacturers Life Insurance) first reported a position in IMMU in Q2 2013 and held it in 29 quarters. The position peaked at $2.31M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Manulife (Manufacturers Life Insurance) reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 4,350 Immunomedics Inc shares in Q4 2020, an estimated $370K.
- Manulife (Manufacturers Life Insurance) first reported a position in Immunomedics Inc in Q2 2013 and held it in 29 quarters.
- Manulife (Manufacturers Life Insurance)'s Immunomedics Inc position peaked at $2.31M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.